- Q3 2024 UPL Ltd Earnings Call TranscriptFeb 02, 2024$17.25Earnings
- Q2 2024 UPL Ltd Earnings Call TranscriptOct 30, 2023$17.25Earnings
- UPL Ltd Annual Shareholders Meeting TranscriptAug 18, 2023
- Q1 2024 UPL Ltd Earnings Call TranscriptJul 31, 2023$17.25Earnings
- UPL Ltd Extraordinary Shareholders Meeting TranscriptJul 20, 2023
- UPL Ltd Capital Markets Day TranscriptMay 08, 2023
- Q3 2023 UPL Ltd Earnings Call TranscriptJan 31, 2023Earnings
- Q2 2023 UPL Ltd Earnings Call TranscriptNov 01, 2022$17.3Earnings
- Q1 2023 UPL Ltd Earnings Call TranscriptAug 01, 2022$17.3Earnings
- UPL Ltd Capital Markets Day TranscriptMay 09, 2022
- Q3 2022 UPL Ltd Earnings Presentation TranscriptJan 31, 2022
- Q2 2022 UPL Ltd Earnings Call TranscriptOct 29, 2021Earnings
- UPL Ltd Annual Shareholders Meeting TranscriptAug 06, 2021
- Q1 2022 UPL Ltd Earnings Call TranscriptJul 30, 2021Earnings
- UPL Ltd Capital Markets Day TranscriptMay 12, 2021
- Q3 2021 UPL Ltd Earnings Call TranscriptJan 29, 2021Earnings
- UPL Ltd Discussing the Response to the Recent News Reports in the Media Call TranscriptDec 10, 2020
- Q2 2021 UPL Ltd Earnings Call TranscriptOct 30, 2020Earnings
- UPL Ltd Annual Shareholders Meeting TranscriptAug 31, 2020
- Q1 2021 UPL Ltd Earnings Call TranscriptJul 31, 2020Earnings
- UPL Ltd Capital Markets Day TranscriptMay 22, 2020
- Q3 2020 UPL Ltd Earnings Call TranscriptFeb 07, 2020Earnings
- Q2 2020 UPL Ltd Earnings Call TranscriptNov 07, 2019Earnings
- Q1 2020 UPL Ltd Earnings Call TranscriptJul 31, 2019Earnings
- UPL Ltd Capital Markets Day TranscriptMay 17, 2019
- Novozymes A/S to Discuss the Continuation of Partnership with Bayer AG and with Two New Partners, Univar Solutions and UPL Ltd Call TranscriptApr 05, 2019
Novozymes A/S to Discuss the Continuation of Partnership with Bayer AG and with Two New Partners, Univar Solutions and UPL Ltd Call Transcript
Welcome to the Novozymes conference call on the future setup of the Novozymes BioAg business. I will now hand it over to the 2 presenters from Novozymes. Please go ahead.
¥¸,/-&
Good morning, everyone, and thank you for joining the call. Today, we will present the future setup of our BioAg business. My name is Tina Sejersgård Fanø, and I'm the Executive Vice President for the Agriculture and Bioenergy business. I'm joined here today by our CFO, Prisca Havranek-Kosicek, and Investor Relations. The presentation should take around 10 to 15 minutes. And after that, we'll answer your questions.
We are very happy to announce the outcome of the negotiations we have had with Bayer and other parties over the last quarters. But before getting into the details of that, I would like to remind you of the importance of our BioAg business and the reason for forming The BioAg Alliance with Monsanto 5 years ago.
During
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)